rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Laura Berner

Director

Company insider

Files Form 4 as: Director, Bolt Biotherapeutics.

In numbers

Trades disclosed
17
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
14 Dec 2022
Last trade
10 Jun 2026
Last filed
11 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
BOLT Bolt BiotherapeuticsDirector · Biotechnology · last 10 Jun 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
10 Jun 2026filed 11 Jun 2026BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—5,000 at $0.00filing
10 Jun 2026filed 11 Jun 2026BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—5,000 at $0.00filing
12 Dec 2025filed 16 Dec 2025BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—2,500filing
12 Dec 2025filed 16 Dec 2025BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—2,500filing
12 Dec 2025filed 16 Dec 2025BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—613filing
12 Dec 2025filed 16 Dec 2025BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—613filing
12 Dec 2025filed 16 Dec 2025BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—1,250filing
12 Dec 2025filed 16 Dec 2025BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—1,250filing
12 Dec 2025filed 16 Dec 2025BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—1,100filing
12 Dec 2025filed 16 Dec 2025BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—1,100filing
12 Dec 2025filed 16 Dec 2025BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—1,100filing
12 Dec 2025filed 16 Dec 2025BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—1,100filing
27 May 2025filed 2 Jul 2025BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—1,100 at $0.00filing
12 Jun 2024filed 14 Jun 2024BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—22,000 at $0.00filing
12 Jun 2023filed 14 Jun 2023BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
14 Dec 2022filed 16 Dec 2022BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
14 Dec 2022filed 16 Dec 2022BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—12,261 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Grant YonehiroChief Operating Officer · Chief Operating Officer at Bolt Biotherapeutics, filing Form 4 there in the last year
William P. QuinnPresident, CEO and CFO · President, CEO and CFO at Bolt Biotherapeutics, filing Form 4 there in the last year
Sarah NemecSenior VP, Finance and PAO · Senior VP, Finance and PAO at Bolt Biotherapeutics, filing Form 4 there in the last year
Kathleen LaporteDirector · Director at Bolt Biotherapeutics, filing Form 4 there in the last year
Jakob DupontDirector · Director at Bolt Biotherapeutics, filing Form 4 there in the last year